Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

24 June 2021: Clinical Research

An Individualized Contrast-Enhanced Liver Computed Tomography Imaging Protocol Based on Body Mass Index in 126 Patients Seen for Liver Cirrhosis

Jian Jiang ABCEG , Maowei Zhang BD , Yuan Ji BCDF , Chunfeng Li CD , Xin Fang BF , Shuyuan Zhang B , Wei Wang CF , Lijun Wang EF , Ailian Liu ACEF*

DOI: 10.12659/MSM.932109

Med Sci Monit 2021; 27:e932109

Figure 4 Scans from a 75-year-old woman (body mass index, 28.1 kg/m2) with hepatitis B cirrhosis. Liver CT was performed at 120 kV (size-specific dose estimate, 16.04 mGy) and contrast medium 550 mg I/kg. (A) Non-enhanced, (B) late arterial, (C) portal venous, and (D) delay phase images; and (E, F) 3D volume-rendering of reconstruction images, with arteries in yellow and tumor in blue. A hypervascular tumor can be seen in the liver, with hypodensity (A), hypervascularity (B), and washout (C, D) relative to the liver parenchyma. Three-dimensional volume-rendering reconstruction images show the relationship between the arteries and the tumor (E, F). The tumor diagnosis of hepatocellular carcinoma was confirmed by pathology.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750